Our DPI pipeline is built on a strong foundation of innovation, scientific rigor, and market relevance — focusing on respiratory therapies for asthma, COPD, and related conditions.

• Par with innovator brands: Our formulations are developed to match the performance of leading global brands, ensuring therapeutic equivalence and market readiness.
• In-vitro studies completed: Each product in our pipeline undergoes extensive in-vitro characterization to support quality, efficacy, and regulatory documentation.